OPKO HEALTH, INC.
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
OPKO Health is a diversified healthcare company operating through two main segments: diagnostics, including BioReference Laboratories' clinical testing services, and pharmaceuticals, which develops and markets prescription drugs and biologics such as its growth hormone therapy Ngenla. It also pursues research in areas like precision medicine and proprietary drug delivery technologies.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| PAGANELLI JOHN ADirector | Sell | $8K | 4,426at $1.78 | Nov 5, 2026 |
| PAGANELLI JOHN ADirector | Sell | $17K | 9,175at $1.82 | Nov 5, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable OPK activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.